A randomized phase III study of docetaxel alone versus docetaxel plus S‐1 in patients with previously treated non‐small cell lung cancer: JMTO LC09‐01

A randomized phase III study of docetaxel alone versus docetaxel plus S‐1 in patients with previously treated non‐small cell lung cancer: JMTO LC09‐01

Abstract Background This study evaluated the efficacy and safety of the combination chemotherapy of docetaxel plus S‐1 in patients with previously treated non‐small cell lung cancer (NSCLC) compared to docetaxel alone. Methods Patients with previously treated NSCLC were randomly assigned to docetaxe...

Full description

Bibliographic Details
Main Authors: Shinji Atagi, Takashi Daimon, Kyoichi Okishio, Kiyoshi Komuta, Yoshio Okano, Koichi Minato, Young Hak Kim, Ryo Usui, Chiharu Tabata, Atsuhisa Tamura, Masaaki Kawahara
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Thoracic Cancer
Subjects:
docetaxel
non‐small cell lung cancer
previously treated
S‐1
Online Access:https://doi.org/10.1111/1759-7714.15080

Internet

https://doi.org/10.1111/1759-7714.15080

Similar Items